Paradigm Biocapital Advisors LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$2613.0T
Holdings
35
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 4,571,678 | $346.8T | 13.27% | |
| 2 | ARGXARGENX SE | 538,139 | $231.4T | 8.86% | |
| 3 | ACLXARCELLX INC | 3,848,095 | $212.4T | 8.13% | |
| 4 | RVMDREVOLUTION MEDICINES INC | 5,259,089 | $204.1T | 7.81% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 947,574 | $149.7T | 5.73% | |
| 6 | IRONDISC MEDICINE INC | 2,704,718 | $121.9T | 4.67% | |
| 7 | MRUSMERUS N V | 2,019,814 | $119.5T | 4.57% | |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 2,513,302 | $112.6T | 4.31% | |
| 9 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 2,330,508 | $95.3T | 3.65% | |
| 10 | KURAKURA ONCOLOGY INC | 4,539,381 | $93.5T | 3.58% | |
| 11 | ASNDASCENDIS PHARMA A/S | 664,307 | $90.6T | 3.47% | |
| 12 | OLMAOLEMA PHARMACEUTICALS INC | 7,903,600 | $85.5T | 3.27% | |
| 13 | XENEXENON PHARMACEUTICALS INC | 2,043,280 | $79.7T | 3.05% | |
| 14 | TARSTARSUS PHARMACEUTICALS INC | 2,435,416 | $66.2T | 2.53% | |
| 15 | JANXJANUX THERAPEUTICS INC | 1,564,452 | $65.5T | 2.51% | |
| 16 | ARVNARVINAS INC | 2,438,149 | $64.9T | 2.48% | |
| 17 | LEGNLEGEND BIOTECH CORP | 1,203,308 | $53.3T | 2.04% | |
| 18 | PCVXVAXCYTE INC | 627,202 | $47.4T | 1.81% | |
| 19 | YMABUSDY-MABS THERAPEUTICS INC | 3,870,594 | $46.8T | 1.79% | |
| 20 | EWTXEDGEWISE THERAPEUTICS INC | 2,325,449 | $41.9T | 1.60% | |
| 21 | IMTXIMMATICS N.V | 3,421,965 | $39.8T | 1.52% | |
| 22 | VRDNVIRIDIAN THERAPEUTICS INC | 2,896,349 | $37.7T | 1.44% | |
| 23 | IMVTIMMUNOVANT INC | 1,362,827 | $36.0T | 1.38% | |
| 24 | COGTCOGENT BIOSCIENCES INC | 3,624,342 | $30.6T | 1.17% | |
| 25 | BBIOBRIDGEBIO PHARMA INC | 1,089,492 | $27.6T | 1.06% | |
| 26 | CGEMCULLINAN THERAPEUTICS INC | 1,542,805 | $26.9T | 1.03% | |
| 27 | ERASERASCA INC | 7,250,000 | $17.1T | 0.65% | |
| 28 | CMPSCOMPASS PATHWAYS PLC | 2,335,926 | $14.1T | 0.54% | |
| 29 | APGEAPOGEE THERAPEUTICS INC | 330,000 | $13.0T | 0.50% | |
| 30 | VRNAVERONA PHARMA PLC | 721,087 | $10.4T | 0.40% | |
| 31 | ALXOALX ONCOLOGY HLDGS INC | 1,575,605 | $9.5T | 0.36% | |
| 32 | CATXPERSPECTIVE THERAPEUTICS INC | 919,692 | $9.2T | 0.35% | |
| 33 | VORVOR BIOPHARMA INC | 6,457,293 | $6.5T | 0.25% | |
| 34 | ACRVACRIVON THERAPEUTICS INC | 659,724 | $3.8T | 0.15% | |
| 35 | TCRXTSCAN THERAPEUTICS INC | 353,886 | $2.1T | 0.08% |